Bioptik Technology Incorporation

TPEX:4161 株式レポート

時価総額:NT$1.8b

Bioptik Technology Incorporation 過去の業績

過去 基準チェック /56

Bioptik Technology Incorporation has been growing earnings at an average annual rate of 63.2%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 11.8% per year. Bioptik Technology Incorporation's return on equity is 13.2%, and it has net margins of 12.4%.

主要情報

63.2%

収益成長率

63.1%

EPS成長率

Medical Equipment 業界の成長11.5%
収益成長率11.8%
株主資本利益率13.2%
ネット・マージン12.4%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

Do Investors Have Good Reason To Be Wary Of Bioptik Technology Incorporation's (GTSM:4161) 1.2% Dividend Yield?

Apr 12
Do Investors Have Good Reason To Be Wary Of Bioptik Technology Incorporation's (GTSM:4161) 1.2% Dividend Yield?

Bioptik Technology Incorporation (GTSM:4161) Is Making Moderate Use Of Debt

Feb 16
Bioptik Technology Incorporation (GTSM:4161) Is Making Moderate Use Of Debt

Is Bioptik Technology Incorporation (GTSM:4161) A Strong Dividend Stock?

Dec 25
Is Bioptik Technology Incorporation (GTSM:4161) A Strong Dividend Stock?

収支内訳

Bioptik Technology Incorporation の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

TPEX:4161 収益、費用、利益 ( )TWD Millions
日付収益収益G+A経費研究開発費
30 Jun 249091139275
31 Mar 24891968573
31 Dec 23829867871
30 Sep 23825688469
30 Jun 23816658464
31 Mar 23776548159
31 Dec 22768488058
30 Sep 22727377854
30 Jun 22699197755
31 Mar 22716237852
31 Dec 21738237949
30 Sep 2167817545
30 Jun 21582-347544
31 Mar 21525-447545
31 Dec 20486-607550
30 Sep 20513-517761
30 Jun 20554-207865
31 Mar 20590-98268
31 Dec 1956658169
30 Sep 1955597970
30 Jun 19532-177266
31 Mar 19500257261
31 Dec 18520266758
30 Sep 18483236550
30 Jun 18453396548
31 Mar 18475-45850
31 Dec 17476-346050
30 Sep 17489-206352
30 Jun 17521-196161
31 Mar 17500-135960
31 Dec 1647786162
30 Sep 16463116160
30 Jun 16441146352
31 Mar 16443106253
31 Dec 15453286047
30 Sep 15463295548
30 Jun 15470285043
31 Mar 15433244840
31 Dec 14415304841
30 Sep 14403574739
30 Jun 14421754938
31 Mar 14453935036
31 Dec 13452794832

質の高い収益: 4161 has high quality earnings.

利益率の向上: 4161's current net profit margins (12.4%) are higher than last year (8%).


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: 4161 has become profitable over the past 5 years, growing earnings by 63.2% per year.

成長の加速: 4161's earnings growth over the past year (73.6%) exceeds its 5-year average (63.2% per year).

収益対業界: 4161 earnings growth over the past year (73.6%) exceeded the Medical Equipment industry 3.5%.


株主資本利益率

高いROE: 4161's Return on Equity (13.2%) is considered low.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘